Jubilant Pharmova reports consolidated net loss of Rs 16 crore in Q3FY23

03 Feb 2023 Evaluate

Jubilant Pharmova has reported results for third quarter ended December 31, 2022. (Q3FY23)

The company has reported net loss of Rs 5.89 crore for Q3FY23 as compared to net loss fo Rs 15.60 crore for the corresponding quarter previous year. However, total income of the company increased by 16.21% to Rs 190.61 crore for the quarter under review as compared to Rs 164.02 crore for the same quarter in the previous year.

On the consolidated basis, the company has reported net loss of Rs 16.04 crore for Q3FY23 as compared to net profit of Rs 50.80 crore for the same quarter in the previous year. However, total income of the company increased by 18.65% to Rs 1561.98 crore for the quarter under review as compared to Rs 1316.44 crore for the same quarter in the previous year.

Jubilant Pharmova Share Price

954.65 -13.60 (-1.40%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×